An international working group held a meeting in the UK on March 25, 2015 to discuss clinical measures that could be used to establish the efficacy of drugs in the treatment of Ataxia of Charlevoix-Saguenay.Read more
Update on Dr. Synofzik's research "A randomised delayed entry trial of intensive home-based speech therapy in ARSACS" project funded by the Foundation.Read more
Dr. Jonathon Burman, Ph.D.researcher(Research Fellow) will study the role of the Sacsin on human cells. Dr. Burman is part of Dr. Richard Youle's research lab at the National Institutes of Health (NIH) Maryland, USA. See Dr. Burman's project abstract.
Preliminary discussions are underway with an american pharmaceutical cie to test a drug for ARSACS (preclinical trial). More information to follow.
A consortium of ARSACS researchers from several countries (Canada, Germany, Netherlands, France, Italy and Turkey) file a letter of intent as part of the E-Rare3 competition. More information to follow.
Olivier Audet will present the results of his study at the Congrès de l’Association Québécoise des Sciences de l’Activité Physique – AQSAP Québec 2015 will be held on February 6 and 7 at Laval University. His study, funded by the Foundation, is to determine the impact of a regular training program on the physical condition and symptoms of spasticity on ARSACS patients.
Activities are currently underway to conduct chronic studies on the administration of a drug in ARSACS mice. A preliminary study was done in 2013 and had positive results. This time, the studies will be done over a longer period of time. More details to come.
The Ataxia Charlevoix-Saguenay Foundation was founded in 2006 to finance scientific research on Autosomal Recessive Spastic Ataxia of Charlevoix-Saguenay (ARSACS).Learn more
Again this year, with Mr. Jacques Bougie as the honorary president, the Dîner des Producteurs had a great success raising over $700,000 for the ARSACS reseach.Learn more
ARSACS is a debilating hereditary and progressive childhood neurological disorder.Learn more